Published in Mol Cell Biol on July 01, 1999
A Rik1-associated, cullin-dependent E3 ubiquitin ligase is essential for heterochromatin formation. Genes Dev (2005) 1.87
Kinetochore and heterochromatin domains of the fission yeast centromere. Chromosome Res (2004) 1.85
Fission yeast mutants that alleviate transcriptional silencing in centromeric flanking repeats and disrupt chromosome segregation. Genetics (1999) 1.55
Transcriptional silencing in Saccharomyces cerevisiae and Schizosaccharomyces pombe. Nucleic Acids Res (2002) 1.27
Human Sug1/p45 is involved in the proteasome-dependent degradation of Sp1. Biochem J (2000) 1.02
Okadaic acid, an inhibitor of protein phosphatase 1 and 2A, induces premature separation of sister chromatids during meiosis I and aneuploidy in mouse oocytes in vitro. Chromosome Res (2003) 0.93
The fission yeast ubiquitin-conjugating enzymes UbcP3, Ubc15, and Rhp6 affect transcriptional silencing of the mating-type region. Eukaryot Cell (2002) 0.89
MG-132, an inhibitor of proteasomes and calpains, induced inhibition of oocyte maturation and aneuploidy in mouse oocytes. Cell Chromosome (2002) 0.88
Two ubiquitin-conjugating enzymes, Rhp6 and UbcX, regulate heterochromatin silencing in Schizosaccharomyces pombe. Mol Cell Biol (2002) 0.86
Chromosomal position effects reveal different cis-acting requirements for rDNA transcription and sex chromosome pairing in Drosophila melanogaster. Genetics (2000) 0.84
The 19S proteasome is directly involved in the regulation of heterochromatin spreading in fission yeast. J Biol Chem (2017) 0.80
Nuclear effects of ethanol-induced proteasome inhibition in liver cells. World J Gastroenterol (2009) 0.78
Transcriptional Activation of Pericentromeric Satellite Repeats and Disruption of Centromeric Clustering upon Proteasome Inhibition. PLoS One (2016) 0.75
Basic local alignment search tool. J Mol Biol (1990) 659.07
Molecular genetic analysis of fission yeast Schizosaccharomyces pombe. Methods Enzymol (1991) 33.90
Structure of 20S proteasome from yeast at 2.4 A resolution. Nature (1997) 12.73
nmt1 of fission yeast. A highly transcribed gene completely repressed by thiamine. J Biol Chem (1990) 8.16
Definition of individual components within the cytoskeleton of Trypanosoma brucei by a library of monoclonal antibodies. J Cell Sci (1989) 6.48
A subcomplex of the proteasome regulatory particle required for ubiquitin-conjugate degradation and related to the COP9-signalosome and eIF3. Cell (1998) 5.78
Construction of a Schizosaccharomyces pombe gene bank in a yeast bacterial shuttle vector and its use to isolate genes by complementation. Mol Gen Genet (1982) 5.17
Cell cycle-dependent specific positioning and clustering of centromeres and telomeres in fission yeast. J Cell Biol (1993) 5.11
Cut2 proteolysis required for sister-chromatid seperation in fission yeast. Nature (1996) 4.86
The case for epigenetic effects on centromere identity and function. Trends Genet (1997) 4.57
Mutations derepressing silent centromeric domains in fission yeast disrupt chromosome segregation. Genes Dev (1995) 4.52
A low copy number central sequence with strict symmetry and unusual chromatin structure in fission yeast centromere. Mol Biol Cell (1992) 3.94
Chromosome walking shows a highly homologous repetitive sequence present in all the centromere regions of fission yeast. EMBO J (1986) 3.92
Position effect variegation at fission yeast centromeres. Cell (1994) 3.51
The chromodomain protein Swi6: a key component at fission yeast centromeres. Science (1995) 3.40
The multicatalytic and 26 S proteases. J Biol Chem (1993) 3.39
Functional analysis of the chromo domain of HP1. EMBO J (1995) 3.30
Mutations in the fission yeast silencing factors clr4+ and rik1+ disrupt the localisation of the chromo domain protein Swi6p and impair centromere function. J Cell Sci (1996) 2.73
The chromo shadow domain, a second chromo domain in heterochromatin-binding protein 1, HP1. Nucleic Acids Res (1995) 2.59
A deubiquitinating enzyme interacts with SIR4 and regulates silencing in S. cerevisiae. Cell (1996) 2.47
Regulating the yeast kinetochore by ubiquitin-dependent degradation and Skp1p-mediated phosphorylation. Cell (1997) 2.42
Telomere-associated chromosome breakage in fission yeast results in variegated expression of adjacent genes. EMBO J (1994) 2.31
Defective mitosis due to a mutation in the gene for a fission yeast 26S protease subunit. Nature (1993) 2.26
Dynamics of proteasome distribution in living cells. EMBO J (1997) 2.18
Characterization of Schizosaccharomyces pombe minichromosome deletion derivatives and a functional allocation of their centromere. EMBO J (1989) 2.14
Heterochromatin protein 1 is required for correct chromosome segregation in Drosophila embryos. J Cell Sci (1995) 2.02
The spindle checkpoint. Trends Genet (1998) 1.83
Mutations in rik1, clr2, clr3 and clr4 genes asymmetrically derepress the silent mating-type loci in fission yeast. Genetics (1994) 1.82
The clr1 locus regulates the expression of the cryptic mating-type loci of fission yeast. Genetics (1992) 1.75
A conditional lethal mutant in the fission yeast 26 S protease subunit mts3+ is defective in metaphase to anaphase transition. J Biol Chem (1996) 1.70
The ubiquitin-conjugating enzyme Rad6 (Ubc2) is required for silencing in Saccharomyces cerevisiae. Mol Cell Biol (1997) 1.63
Cut1 is loaded onto the spindle by binding to Cut2 and promotes anaphase spindle movement upon Cut2 proteolysis. Curr Biol (1998) 1.62
Localization of the 26S proteasome during mitosis and meiosis in fission yeast. EMBO J (1998) 1.61
Three additional linkage groups that repress transcription and meiotic recombination in the mating-type region of Schizosaccharomyces pombe. Genetics (1994) 1.57
UbcD1, a Drosophila ubiquitin-conjugating enzyme required for proper telomere behavior. Genes Dev (1997) 1.54
Centromeres of the fission yeast Schizosaccharomyces pombe are highly variable genetic loci. Mol Cell Biol (1993) 1.42
Resistance to diverse drugs and ultraviolet light conferred by overexpression of a novel human 26 S proteasome subunit. J Biol Chem (1997) 1.37
The switching gene swi6 affects recombination and gene expression in the mating-type region of Schizosaccharomyces pombe. Mol Gen Genet (1992) 1.30
A novel essential fission yeast gene pad1+ positively regulates pap1(+)-dependent transcription and is implicated in the maintenance of chromosome structure. J Cell Sci (1995) 1.27
A proteasome cap subunit required for spindle pole body duplication in yeast. J Cell Biol (1997) 1.27
Fission yeast Cut2 required for anaphase has two destruction boxes. EMBO J (1997) 1.24
Developmental changes of the 26 S proteasome in abdominal intersegmental muscles of Manduca sexta during programmed cell death. J Biol Chem (1995) 1.20
The dose of a putative ubiquitin-specific protease affects position-effect variegation in Drosophila melanogaster. Mol Cell Biol (1996) 1.12
The Pad1+ gene encodes a subunit of the 26 S proteasome in fission yeast. J Biol Chem (1998) 1.11
Changes in proteasome localization during the cell cycle. Eur J Cell Biol (1994) 1.10
Subunits of the regulatory complex of the 26S protease. Mol Biol Rep (1995) 1.09
Cell cycle: oiling the gears of anaphase. Curr Biol (1998) 1.05
Mts4, a non-ATPase subunit of the 26 S protease in fission yeast is essential for mitosis and interacts directly with the ATPase subunit Mts2. J Biol Chem (1997) 1.01
A novel function of the DNA repair gene rhp6 in mating-type silencing by chromatin remodeling in fission yeast. Mol Cell Biol (1998) 0.94
Mutations derepressing silent centromeric domains in fission yeast disrupt chromosome segregation. Genes Dev (1995) 4.52
Transient inhibition of histone deacetylation alters the structural and functional imprint at fission yeast centromeres. Cell (1997) 3.72
Proteins containing the UBA domain are able to bind to multi-ubiquitin chains. Nat Cell Biol (2001) 3.62
Mortality in systemic lupus erythematosus. Arthritis Rheum (2006) 3.61
Position effect variegation at fission yeast centromeres. Cell (1994) 3.51
The chromodomain protein Swi6: a key component at fission yeast centromeres. Science (1995) 3.40
The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med (1993) 3.35
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis (2007) 3.32
Acute generalized exanthematous pustulosis. Analysis of 63 cases. Arch Dermatol (1991) 3.29
Telomeric repeat from T. thermophila cross hybridizes with human telomeres. Nature (1988) 3.20
A comparison of the reliability of self-reported drug use and sexual behaviors using computer-assisted versus face-to-face interviewing. AIDS Educ Prev (2000) 3.02
The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth. Arthritis Rheum (1995) 2.82
Mutations in the fission yeast silencing factors clr4+ and rik1+ disrupt the localisation of the chromo domain protein Swi6p and impair centromere function. J Cell Sci (1996) 2.73
EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis (2010) 2.52
The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum (1997) 2.49
A novel protein complex involved in signal transduction possessing similarities to 26S proteasome subunits. FASEB J (1998) 2.43
BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus. Rheumatology (Oxford) (2005) 2.37
Comparative clinical pharmacology of amoxicillin and ampicillin administered orally. Antimicrob Agents Chemother (1972) 2.35
Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum (1997) 2.31
Telomere-associated chromosome breakage in fission yeast results in variegated expression of adjacent genes. EMBO J (1994) 2.31
Defective mitosis due to a mutation in the gene for a fission yeast 26S protease subunit. Nature (1993) 2.26
The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison. J Rheumatol (2000) 2.26
Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. Arthritis Rheum (2007) 2.18
The role of continuous background infusions in patient-controlled epidural analgesia for labor and delivery. Anesth Analg (1994) 2.17
A cell line-based neutralization assay for primary human immunodeficiency virus type 1 isolates that use either the CCR5 or the CXCR4 coreceptor. J Virol (1999) 2.12
Disablement following stroke. Disabil Rehabil (1999) 2.10
Lon-dependent proteolysis of CcdA is the key control for activation of CcdB in plasmid-free segregant bacteria. Mol Microbiol (1994) 2.02
[Survey of post-graduate training for Dermatology and Venereology residents in France (2005-2010)]. Ann Dermatol Venereol (2013) 2.00
Delay in presentation to primary care physicians is the main reason why patients with rheumatoid arthritis are seen late by rheumatologists. Rheumatology (Oxford) (2007) 1.97
An international cohort study of cancer in systemic lupus erythematosus. Arthritis Rheum (2005) 1.96
The cell cycle genes cdc22+ and suc22+ of the fission yeast Schizosaccharomyces pombe encode the large and small subunits of ribonucleotide reductase. Mol Gen Genet (1993) 1.88
Atherosclerotic vascular events in a multinational inception cohort of systemic lupus erythematosus. Arthritis Care Res (Hoboken) (2010) 1.84
Risk factors for erysipelas of the leg (cellulitis): case-control study. BMJ (1999) 1.79
Regulatory subunit interactions of the 26S proteasome, a complex problem. Trends Biochem Sci (2000) 1.77
The EPISA study: antimicrobial susceptibility of Staphylococcus aureus causing primary or secondary skin and soft tissue infections in the community in France, the UK and Ireland. J Antimicrob Chemother (2008) 1.75
A conditional lethal mutant in the fission yeast 26 S protease subunit mts3+ is defective in metaphase to anaphase transition. J Biol Chem (1996) 1.70
Evaluation of clinical criteria for diagnosis of bullous pemphigoid. French Bullous Study Group. Arch Dermatol (1998) 1.70
Evidence that p53 behaves as a tumour suppressor gene in sporadic breast tumours. Oncogene (1990) 1.70
European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis (2009) 1.69
[Malignant ethmoid bone tumors in woodworkers]. J Med Lyon (1969) 1.68
From BILAG to BLIPS--disease activity assessment in lupus past, present and future. Lupus (2000) 1.68
Accumulation of coronary artery disease risk factors over three years: data from an international inception cohort. Arthritis Rheum (2008) 1.65
Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis. Lancet (1990) 1.64
Calcifying fibrous pseudotumour: first case report in the peritoneum with immunostaining for CD34. Histopathology (1999) 1.63
Associates of health status in patients with systemic lupus erythematosus. J Rheumatol (1999) 1.62
Localization of the 26S proteasome during mitosis and meiosis in fission yeast. EMBO J (1998) 1.61
A fission yeast chromosome can replicate autonomously in mouse cells. Cell (1987) 1.60
Fission yeast genes which disrupt mitotic chromosome segregation when overexpressed. Nucleic Acids Res (1996) 1.58
Kinetics of gentamicin uptake and release in the rat. Comparison of inner ear tissues and fluids with other organs. J Clin Invest (1986) 1.57
Cloning and analysis of the entire Escherichia coli ams gene. ams is identical to hmp1 and encodes a 114 kDa protein that migrates as a 180 kDa protein. J Mol Biol (1992) 1.57
Fission yeast mutants that alleviate transcriptional silencing in centromeric flanking repeats and disrupt chromosome segregation. Genetics (1999) 1.55
Trainable rule-based algorithm for the measurement of joint space width in digital radiographic images of the knee. Med Phys (2000) 1.52
Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid. Arch Dermatol (1993) 1.52
Study of the apoptosis induced in vitro by antitumoral drugs on leukaemic cells. Leuk Res (1997) 1.50
Evaluation of BioStar FLU OIA assay for rapid detection of influenza A and B viruses in respiratory specimens. J Clin Virol (2000) 1.49
Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthritis Rheum (1994) 1.48
The association of socio-economic status, race, psychosocial factors and outcome in patients with systemic lupus erythematosus. Rheumatology (Oxford) (1999) 1.45
Heat shock at an elevated temperature improves transformation efficiency of protoplasts from Podospora anserina. J Gen Microbiol (1989) 1.44
Validation of recombinant Sendai virus in a non-natural host model. Gene Ther (2010) 1.42
Clinical and histological features of head and neck melanoma: a population-based study in France. Br J Dermatol (2015) 1.42
Role of drug exposure in aphthous ulcers: a case-control study. Br J Dermatol (2000) 1.39
The role of general practitioners in diagnosis of cutaneous melanoma: a population-based study in France. Br J Dermatol (2012) 1.39
Primary identification of Microbacterium spp. encountered in clinical specimens as CDC coryneform group A-4 and A-5 bacteria. J Clin Microbiol (1995) 1.38
Cloxacillin versus pristinamycin for superficial pyodermas: a randomized, open-label, non-inferiority study. Dermatology (2005) 1.38
[Haemorrhagic cellulitis: three cases]. Ann Dermatol Venereol (2003) 1.38
The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case-cohort study. Ann Rheum Dis (2007) 1.37
Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemia. Leukemia (1997) 1.36
Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study. Arthritis Rheum (2008) 1.34
The domain structure of centromeres is conserved from fission yeast to humans. Mol Biol Cell (2001) 1.33
The repertoire of serum IgM in normal mice is largely independent of external antigenic contact. Eur J Immunol (1997) 1.32
Modalities of synthesis of Ki67 antigen during the stimulation of lymphocytes. Cytometry (1991) 1.29
A flow cytometric method using Hoechst 33342 and propidium iodide for simultaneous cell cycle analysis and apoptosis determination in unfixed cells. Cytometry (1994) 1.28
Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus. Ann Rheum Dis (2009) 1.27
Calcium in bacteria: a solution to which problem? Mol Microbiol (1991) 1.25
CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo. J Pharmacol Exp Ther (1987) 1.24
Intermediate clinical and radiological results of cervical TDR (Mobi-C) with up to 2 years of follow-up. Eur Spine J (2009) 1.23
Drugs associated with bullous pemphigoid. A case-control study. Arch Dermatol (1996) 1.23
[Adaptation of a cytomegalic virus from fieldmice (Apodemus sylvaticus) on various heterologous cells, human included]. C R Acad Sci Hebd Seances Acad Sci D (1969) 1.23
The systemic lupus erythematosus Tri-nation Study: absence of a link between health resource use and health outcome. Rheumatology (Oxford) (2004) 1.23
Lactobacillus species identification, H2O2 production, and antibiotic resistance and correlation with human clinical status. J Clin Microbiol (1999) 1.22
Sclerotherapy with or without octreotide for acute variceal bleeding. N Engl J Med (1995) 1.21
Analytical methods for thromboxane B2 measurement and validation of radioimmunoassay by gas liquid chromatography-mass spectrometry. Prostaglandins (1978) 1.21
Assessment of flares in lupus patients enrolled in a phase II/III study of rituximab (EXPLORER). Lupus (2011) 1.21
Developmental changes of the 26 S proteasome in abdominal intersegmental muscles of Manduca sexta during programmed cell death. J Biol Chem (1995) 1.20
Scorpion toxins: chemistry and mode of action. Adv Cytopharmacol (1979) 1.20
Analysis of a gene encoding Rpn10 of the fission yeast proteasome reveals that the polyubiquitin-binding site of this subunit is essential when Rpn12/Mts3 activity is compromised. J Biol Chem (2000) 1.20
Randomized clinical trials and longitudinal observational studies in systemic lupus erythematosus: consensus on a preliminary core set of outcome domains. J Rheumatol (1999) 1.19
Allele losses on chromosome 17 in human epithelial ovarian carcinoma. Oncogene (1990) 1.19
The organization and results of a pregnancy termination service in a National Health Service hospital. J Obstet Gynaecol Br Commonw (1974) 1.19
Non-Hodgkin's lymphoma in systemic lupus erythematosus. Ann Rheum Dis (2005) 1.19
Invariance and restriction toward a limited set of self-antigens characterize neonatal IgM antibody repertoires and prevail in autoreactive repertoires of healthy adults. Proc Natl Acad Sci U S A (1995) 1.18
Ultrasound guidance allows accurate needle placement and aspiration from small joints in patients with early inflammatory arthritis. Rheumatology (Oxford) (2003) 1.18
Comparison between single- and multi-level patients: clinical and radiological outcomes 2 years after cervical disc replacement. Eur Spine J (2011) 1.18
Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus. J Rheumatol (1997) 1.18
Malignancy is increased in ANCA-associated vasculitis. Rheumatology (Oxford) (2004) 1.18
Molecular and physical arrangements of human DNA in HRAS1-selected, chromosome-mediated transfectants. Mol Cell Biol (1986) 1.17